APT Medical (SHSE:688617) ROCE % : 30.86% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is APT Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. APT Medical's annualized ROCE % for the quarter that ended in Mar. 2024 was 30.86%.

APT Medical ROCE % Historical Data

The historical data trend for APT Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical ROCE % Chart

APT Medical Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

24.87

25.87

19.39

21.83

31.59

APT Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															25.08	38.62	36.36	29.64	30.86

APT Medical ROCE % Calculation

APT Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	600.056	/	( ( (2225.978 - 411.877)	+	(2572.982 - 588.17) )	/ 2 )
	=	600.056	/	( (1814.101	+	1984.812)	/ 2 )
	=	600.056	/	1899.4565
	=	31.59 %

APT Medical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	633.58	/	( ( (2572.982 - 588.17)	+	(2608.085 - 486.438) )	/ 2 )
	=	633.58	/	( ( 1984.812	+	2121.647 )	/ 2 )
	=	633.58	/	2053.2295
	=	30.86 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

APT Medical (SHSE:688617) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

APT Medical ROCE % Related Terms

Thank you for viewing the detailed overview of APT Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

APT Medical (SHSE:688617) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000

Website

http://www.aptmed.com

APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.

Executives

Dai Zhen Hua	Directors, senior managers
Cheng Zheng Hui	Directors, senior managers
Zhang Yong	Core technical personnel
Liu Fang Yuan	senior management
Wang Wei	senior management
	Senior management, core technical personnel
Xu Yi Qing	Directors, senior managers
Han Yong Gui	Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines